E6130, a Novel CX3CR1 Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1+ Leukocyte Trafficking in Two Murine Colitis Models

Molecular Pharmacology - United States
doi 10.1124/mol.117.108381
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)


Related search